Intelligent Bio Solutions Inc.
INBS· Nasdaq
INBSIntelligent Bio Solutions Inc.
Filed Feb 11, 2022 · 10-Q · 42 days after period end · 0001493152-22-003848
| Metric | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|
| Revenue | $177.79K | $283.04K | -$798.00 |
| Net Income | -$3.46M | -$1.98M | -$1.84M |
| EPS Diluted | -$0.23 | -$0.23 | -$0.22 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 11, 2022 · 42 d after period end
